Patents: From Invention to Commercialization in the Biomedical Space

The Office of Technology Commercialization
Presents

Invention 2 Innovation (I2I)

Patents: From Invention to Commercialization in the Biomedical Space

Wed., April 17, 2019
12:00 pm – 1:30 pm

Building D, Warwick Evans Conference Room (New Location)

Presented By

Dr. Ling Zhong, Ph.D., Shareholder

Mr. James M. Gould, Counsel   

Ratner Prestia

Recent legal developments are having a profound effect on critical patent issues in the biomedical space. This seminar will cover the latest trends and strategies including:

• Patentability issues associated with inventions relating to biomarkers, diagnostics, new uses of known drugs, new formulations of known drugs, new dosage regimes, and new combinations
• The interplay between patent-based exclusivity and the various FDA-based exclusivities
• Patent issues arising from collaboration between inventors and sponsors of clinical trials